Suppr超能文献

二氢吡啶受体和细胞内钙库在成肌细胞融合中的作用。

Involvement of the dihydropyridine receptor and internal Ca2+ stores in myoblast fusion.

作者信息

Seigneurin-Venin S, Parrish E, Marty I, Rieger F, Romey G, Villaz M, Garcia L

机构信息

INSERM U153, Paris, France.

出版信息

Exp Cell Res. 1996 Mar 15;223(2):301-7. doi: 10.1006/excr.1996.0085.

Abstract

The process of myoblast fusion during skeletal myogenesis is calcium regulated. Both dihydropyridine receptor and ryanodine receptor are already present on muscle precursors, at the prefusional stage, before they are required for excitation-contraction coupling. Previous pharmacological studies have shown the need for a special pool of Ca2+ associated with the membrane for the fusion process to occur. We hypothesized that this pool of Ca2+ is mobilized via a machinery similar to that involved in excitation-contraction coupling. The process of fusion in rat L6 muscle precursors was either totally or partially abolished in the presence of the L-type calcium channel inhibitors SR33557 and nifedipine (half inhibition towards 2 microM), respectively. The inhibition was reversible and dose-dependent. Drugs able to deplete internal calcium stores (caffeine, ryanodine, and thapsigargin) were also tested on the fusion. Both caffeine and thapsigargin drastically inhibited fusion whereas ryanodine had no effect. This suggests that fusion may be controlled by internal pools of Ca2+ but that its regulation may be insensitive to ryanodine. We presumed that an early form of the ryanodine receptor may exist, with different pharmacological properties than the adult forms. Indeed, Western blot analysis of pre- and postfusional L6 cells demonstrated the presence, at the prefusional stage, of a transient form of the ryanodine receptor protein with an apparent molecular weight slightly different from those of the classical skeletal and cardiac forms. Taken together, these results support the hypothesis that the fusion process is driven by a mechanism involving both the dihydropyridine receptor (alpha1 subunit of the L-type Ca2+ channel) and the internal stores of Ca2+. The machinery underlying this mechanism might consist of slightly different forms of the classic molecules that in adult muscle ensure excitation-contraction coupling. It remains to be seen, however, whether the mobilization of the internal pool of Ca2+ is triggered by the type of mechanism already described in skeletal muscle.

摘要

在骨骼肌生成过程中,成肌细胞融合的过程受钙调节。在兴奋 - 收缩偶联需要二氢吡啶受体和兰尼碱受体之前,它们就已经存在于肌肉前体细胞的融合前阶段。先前的药理学研究表明,融合过程的发生需要与膜相关的特殊钙池。我们推测,这个钙池是通过类似于兴奋 - 收缩偶联所涉及的机制来动员的。在存在L型钙通道抑制剂SR33557和硝苯地平(对2 microM的半数抑制)的情况下,大鼠L6肌肉前体细胞的融合过程分别完全或部分被阻断。这种抑制是可逆的且呈剂量依赖性。还对能够耗尽细胞内钙储存的药物(咖啡因、兰尼碱和毒胡萝卜素)对融合的影响进行了测试。咖啡因和毒胡萝卜素都显著抑制融合,而兰尼碱没有作用。这表明融合可能受细胞内钙池控制,但其调节可能对兰尼碱不敏感。我们推测可能存在早期形式的兰尼碱受体,其药理学特性与成年形式不同。实际上,对融合前和融合后的L6细胞进行的蛋白质印迹分析表明,在融合前阶段存在一种瞬时形式的兰尼碱受体蛋白,其表观分子量与经典的骨骼肌和心脏形式略有不同。综上所述,这些结果支持以下假设:融合过程是由一种涉及二氢吡啶受体(L型钙通道的α1亚基)和细胞内钙储存的机制驱动的。该机制的基础可能由成年肌肉中确保兴奋 - 收缩偶联的经典分子的略有不同形式组成。然而,细胞内钙池的动员是否由骨骼肌中已描述的机制类型触发,仍有待观察。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验